Literature DB >> 19669677

Endoscopic diagnosis of intraductal papillary mucinous neoplasm of the bile duct.

Toshio Tsuyuguchi1, Yuji Sakai, Harutoshi Sugiyama, Kaoru Miyakawa, Takeshi Ishihara, Masayuki Ohtsuka, Masaru Miyazaki, Osamu Yokosuka.   

Abstract

BACKGROUND/
PURPOSE: Intraductal papillary mucinous neoplasm of the bile duct (IPMN-B) is considered an uncommon tumor. The purpose of this study was to evaluate the diagnostic utility of endoscopic cholangiography (ERC) with subsequent peroral cholangioscopy (POCS) and/or intraductal ultrasonography (IDUS) for this tumor.
METHODS: From December 1991 to November 2006, a retrospective analysis was made of eight patients with IPMN-B. Their clinical features and the endoscopic diagnostic strategy for POCS and IDUS were reviewed.
RESULTS: In all the patients, ERC failed to show papillary tumors, due to coexisting mucin or biliary sludge. POCS was carried out after ERC and it showed the presence and locations of papillary tumors in all patients, except for one with a tumor in the peripheral intrahepatic bile duct (B3). IDUS was performed in seven of the eight patients; in five of these patients, intraductal protruding tumors were clearly visualized, whereas flat tumors were not identified in the remaining two patients. In one of the eight patients, endoscopic nasobiliary drainage did not remove the huge amount of mucin. Hence, this patient required subsequent percutaneous biliary drainage. Six of the eight patients underwent surgical treatment; five patients underwent a hepatic resection with or without extrahepatic bile duct resection and one underwent a pancreaticoduodenectomy. Five of the six operated patients are still alive; one patient died of gastric cancer 90 months after the operation (mean follow-up period, 45.3 months). The two remaining patients, who were considered inoperable due to major medical comorbidities, died of liver failure and cholangitis 3 and 6 months, respectively, after stent placement.
CONCLUSION: ERC failed to delineate intraductal papillary tumors, due to coexisting mucin. The presence and location of papillary tumors were correctly diagnosed by both POCS and IDUS, but POCS may be better than IDUS to diagnose the extent of the tumor.

Entities:  

Mesh:

Year:  2009        PMID: 19669677     DOI: 10.1007/s00534-009-0153-z

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  11 in total

1.  [74-year-old patient with cystic pancreatic lesions. An endoscopy-based algorithm].

Authors:  S Wörmann; A Meining; M Hartel; L Ludwig; C Prinz; J Gaa; S Schulz; R M Schmid; H Algül
Journal:  Internist (Berl)       Date:  2011-03       Impact factor: 0.743

2.  [Polycyclic space-occupying mass in the left bile duct].

Authors:  J Buhr; E H Allemeyer; K M Müller; M Glados; M W Hoffmann
Journal:  Chirurg       Date:  2014-07       Impact factor: 0.955

3.  Recurrence After Resection for Intraductal Papillary Neoplasm of Bile Duct (IPNB) According to Tumor Location.

Authors:  Yunghun You; Seong Ho Choi; Dong Wook Choi; Jin Seok Heo; In Woong Han; Kee-Taek Jang; Sunjong Han
Journal:  J Gastrointest Surg       Date:  2019-05-06       Impact factor: 3.452

4.  Mucin-producing Cystic Hepatobiliary Neoplasms: Updated Nomenclature and Clinical, Pathologic, and Imaging Features.

Authors:  Matthew H Lee; Venkata S Katabathina; Meghan G Lubner; Hardik U Shah; Srinivasa R Prasad; Kristina A Matkowskyj; Perry J Pickhardt
Journal:  Radiographics       Date:  2021-10       Impact factor: 6.312

5.  Intraductal papillary neoplasm of the bile duct accompanying biliary mixed adenoneuroendocrine carcinoma.

Authors:  Ichiro Onishi; Hirohisa Kitagawa; Kenichi Harada; Syogo Maruzen; Seisyo Sakai; Isamu Makino; Hironori Hayashi; Hisatoshi Nakagawara; Hidehiro Tajima; Hiroyuki Takamura; Takashi Tani; Masato Kayahara; Hiroko Ikeda; Tetsuo Ohta; Yasuni Nakanuma
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

6.  Malignant infiltrating intraductal papillary mucinous neoplasm with internal fistula: one case report and clinical practice.

Authors:  Xiao-Liang Zhu; Wen-Bo Meng; Lei Zhang; Wen-Ce Zhou; Xun Li
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 7.  Intraductal papillary neoplasm of the bile duct.

Authors:  Xue-Shuai Wan; Yi-Yao Xu; Jun-Yan Qian; Xiao-Bo Yang; An-Qiang Wang; Lian He; Hai-Tao Zhao; Xin-Ting Sang
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

8.  A case of branch duct type intraductal papillary neoplasm of the bile duct treated by open surgery after 11 years of follow-up.

Authors:  Mitsuru Fujita; Noritaka Wakui; Yoshiya Yamauchi; Yuki Takeda; Takemasa Sato; Nobuo Ueki; Takafumi Otsuka; Nobuyuki Oba; Shuta Nishinakagawa; Masami Minagawa; Yasushi Takeda; Saori Shiono; Tatsuya Kojima
Journal:  Mol Clin Oncol       Date:  2013-07-25

9.  Occult mucin-producing cholangiocarcinoma in situ: a rare clinical case with difficult tumour staging.

Authors:  Muneyasu Kiriyama; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Gen Sugawara; Takashi Mizuno; Junpei Yamaguchi; Masato Nagino
Journal:  Surg Case Rep       Date:  2017-01-04

Review 10.  Intraductal papillary neoplasms of the bile duct.

Authors:  Masayuki Ohtsuka; Hiroaki Shimizu; Atsushi Kato; Hideyuki Yoshitomi; Katsunori Furukawa; Toshio Tsuyuguchi; Yuji Sakai; Osamu Yokosuka; Masaru Miyazaki
Journal:  Int J Hepatol       Date:  2014-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.